Amenamevir

Antiviral drug
{{Drugbox | Verifiedfields = changed | verifiedrevid = 477002015 | IUPAC_name = (2S)-2-[[4-(2-amino-1,3-thiazol-4-yl)phenyl]methyl]-1,4-dioxaspiro[4.5]decane-2,3-dione | image = Amenamevir.svg | width = 200 | tradename = | Drugs.com = | pregnancy_AU = | pregnancy_US = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number = 841301-32-4 | ATC_prefix = | ATC_suffix = | PubChem = 11525743 | DrugBank = | ChemSpiderID = 9702971 | UNII = | KEGG = | ChEBI = | ChEMBL = | synonyms = ASP2151 | C=16 | H=16 | N=2 | O=4 | S=1 | smiles = O=C1OC2(CCCCC2)C1(Cc3ccc(cc3)c4nc(sc4)N)O | StdInChI = 1S/C16H16N2O4S/c17-15-18-12(11-23-15)10-8-6-9(7-10)5-16(20)13(19)22-14(16)21-4-2-1-3-11-21/h6-8,11H,1-5H2,(H2,17,18) | StdInChIKey = QXKJXQFZKQJZQF-UHFFFAOYSA-N }}
Amenamevir is an antiviral drug that is used for the treatment of herpes zoster (shingles). It is a member of the oxadiazole class of compounds and works by inhibiting the helicase-primase complex of the herpes simplex virus (HSV) and varicella-zoster virus (VZV).
Mechanism of Action[edit]
Amenamevir targets the helicase-primase complex, which is essential for the replication of HSV and VZV. By inhibiting this complex, amenamevir prevents the viral DNA from unwinding and replicating, thereby halting the spread of the virus within the host.
Clinical Use[edit]
Amenamevir is primarily used to treat herpes zoster, a condition caused by the reactivation of the varicella-zoster virus. It is particularly useful in patients who are resistant to other antiviral medications such as acyclovir and valacyclovir.
Side Effects[edit]
Common side effects of amenamevir include headache, nausea, and diarrhea. More severe side effects are rare but can include allergic reactions and liver enzyme abnormalities.
Related Compounds[edit]
Amenamevir is related to other antiviral drugs such as acyclovir, valacyclovir, and famciclovir. These drugs also target the replication mechanisms of herpes viruses but through different mechanisms.
See Also[edit]
References[edit]
This antiviral drug related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian